Heterobicyclic and tricyclic nitric oxide synthase inhibitors
US6489323B1 · kind B1 · utility
0Cited by
36References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 1999 |
| Grant date | Dec 3, 2002 |
| Priority date | — |
| Expiry date | Jun 10, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The current invention relates to compounds of Formula I pharmaceutical compositions and methods of use as nitric oxide synthase inhibitors, wherein the substituents are defined in the application.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.